Workflow
GRACE LIFE-TECH(02112)
icon
Search documents
恩典生命科技(02112) - 2023 - 年度财报
2024-03-28 14:55
Financial Performance - For the fiscal year ending December 31, 2023, the company generated revenue of $8.6 million from iron ore sales, a significant increase from $2.8 million in the previous year, attributed to high international iron ore prices and the recovery of mining operations post-COVID[23] - Revenue for 2023 was approximately $27 million, a decrease of about 15.6% compared to $32 million in 2022[32] - The company recorded an annual loss of $40 million in 2023, a reduction of approximately 29% from the $56 million loss in 2022[32] - The gross profit for 2023 was around $2.8 million, compared to $2.5 million in 2022, indicating a slight improvement[32] - The gross margin improved to 10.45% in 2023 from 7.85% in 2022, reflecting better operational efficiency[27] - The company reported a net loss attributable to owners of approximately $39.57 million for the year ended December 31, 2023[184] Cost Management - The company's cost of sales for the fiscal year was approximately $24.4 million, a decrease of about 18% compared to $29.8 million in 2022, primarily due to reduced costs associated with iron ore and health products[24] - The company’s administrative expenses decreased by approximately 30.5% to about $4.1 million from $5.9 million in the previous year[64] - Financing costs increased by approximately 14.3% to about $15.2 million, up from $13.3 million in the previous year[64] Business Strategy and Expansion - The company plans to accelerate its expansion into electronic products and other fast-moving consumer goods while maintaining its diversified business strategy[17] - The company’s diversified business strategy has shown initial success, leading to a focus on expanding its core plant stem cell business while exploring new opportunities[17] - The plant stem cell business has become a significant revenue source, contributing to the overall growth of the company[34] - The company is focusing on diversifying its business and income sources in response to global economic and political changes[166] Market Trends - The health supplement market in China is experiencing rapid growth, with a penetration rate of 11% among the 35-44 age group, compared to 51% in the U.S., indicating significant potential for future growth[18] - The demand for health supplements is driven by increasing consumer awareness of health and wellness, particularly post-pandemic[18] - The health supplement market in China exceeded RMB 300 billion in 2023, driven by increasing health awareness and consumer demand[37] Operational Efficiency - The company continues to outsource its iron ore business to local teams in Malaysia, which has resulted in improved operational conditions and economic benefits[31] - Trade receivables decreased by 21% to $89.5 million from $113.9 million in the previous year[27] - Total assets decreased by 18% to $108.9 million from $133.6 million in 2022[27] Financial Health - The current ratio decreased to 0.4 in 2023 from 0.6 in 2022, indicating a decline in short-term financial health[27] - As of December 31, 2023, the company's current liabilities amounted to approximately $225.4 million, with a current ratio of 0.4, down from 0.5 in the previous year[46] - The company has cash and cash equivalents totaling approximately $131,000, indicating significant liquidity challenges[184] Governance and Compliance - The board is committed to maintaining appropriate corporate governance practices to protect shareholder interests and ensure compliance with legal standards[118] - The company has established an audit committee to oversee financial reporting procedures and internal controls[128] - The audit committee has held two meetings during the fiscal year, ensuring oversight of financial reporting and compliance[158] - The board confirmed the responsibility for preparing the consolidated financial statements and ensuring compliance with applicable regulations[136] Risk Management - The company has identified significant risks related to the economic downturn in China, particularly in the steel industry, which has led to overcapacity[142] - The company will continue to monitor daily operations and conduct regular internal audits and risk assessments[143] - The group conducts ongoing risk management activities, assessing the effectiveness of its risk management framework at least annually[189] Shareholder Communication - The company has established a shareholder communication policy to ensure timely and effective communication with all shareholders[169] - The company emphasizes transparency and communication with shareholders to enhance governance practices[151] Future Outlook - The global iron ore supply is expected to increase by 62 million tons in 2024, with China's import volume projected to rise by approximately 4 million tons[20] - The company aims to enhance its research and development in plant stem cell products to maintain its technological advantage and leadership in the industry[10]
恩典生命科技(02112) - 2023 - 年度业绩
2024-03-28 14:55
Financial Performance - Revenue for the year ended December 31, 2023, was $27,255,000, a decrease of 16% compared to $32,347,000 in 2022[7] - Loss attributable to owners of the company improved to $(39,566,000), a 29% reduction from $(55,740,000) in the previous year[7] - The company's revenue for 2023 was approximately $27 million, a decrease of about 15.6% compared to $32 million in 2022[17] - The annual loss recorded in 2023 was $40 million, a reduction of about 29% from the $56 million loss in 2022[17] - The company's sales revenue for the year ended December 31, 2023, was $27.26 million, a decrease of 15.7% compared to $32.35 million in 2022[33] - The gross profit for the year ended December 31, 2023, was approximately $2.85 million, reflecting a 12.2% increase from $2.54 million in 2022, attributed to cost control measures[37] - Administrative expenses decreased by approximately 30.5% to $4.1 million in 2023 from $5.9 million in 2022, mainly due to reduced legal and professional fees[38] - The company recorded a loss of approximately $39.6 million for the year ended December 31, 2023, an improvement from a loss of $55.7 million in 2022, primarily due to a reduction in financial asset impairment losses[43] Business Operations - The plant stem cell business showed strong growth, becoming a significant revenue source and a strategic component of the company's overall operations[20] - The iron ore business was successfully outsourced to a local Malaysian team, resulting in improved operational conditions and economic benefits[21] - Revenue from iron ore sales significantly increased to $8.59 million in 2023, up 211.5% from $2.76 million in 2022, driven by high international iron ore prices and increased production capacity post-COVID[35] - The company plans to continue strengthening research and development in plant stem cell products to maintain technological advantages[13] - The iron ore business in Malaysia is expected to achieve steady growth through an outsourcing model, which has proven effective in reducing production costs[16] - The company plans to accelerate its expansion into electronic products and other fast-moving consumer goods while maintaining its diversified business strategy[24] Market and Economic Environment - The current economic environment is anticipated to support business development, with a focus on maintaining competitiveness and creating value for shareholders[16] - The health supplement market in China exceeded RMB 300 billion in 2023, driven by increased consumer health awareness and demand[25] - For the year 2024, global iron ore supply is expected to increase by 62 million tons, with domestic iron ore production in China projected to rise by 15 million tons due to the resumption of old mines and new capacity coming online[29] - China's iron ore imports from January to November 2023 reached 107.8 million tons, with a year-on-year increase of 6.2%[28] Sustainability and Environmental Impact - The company aims to enhance sustainability and resource efficiency, with minimal water, electricity, and other natural resource usage due to a focus on commodity trading in fiscal years 2022 and 2023[168] - The company has established a comprehensive materiality assessment to guide future environmental, social, and governance (ESG) work plans and goals, ensuring sustainable value creation for stakeholders[157] - The company reported compliance with all relevant environmental laws and regulations in Hong Kong, China, and Malaysia, with no confirmed incidents of non-compliance or complaints[160] - The company has implemented measures to optimize mining methods and processing technologies to reduce mining loss rates and improve recovery rates, thereby minimizing environmental impact[166] - The total carbon dioxide emissions from employee business flights amounted to 13,450 kg in the fiscal year 2023, a significant increase from 4,090 kg in 2022, with a total of 47 flights taken[165] Governance and Compliance - The company has complied with the corporate governance code, with deviations disclosed in the corporate governance report[78] - The audit committee reviewed the audited financial statements for the year ended December 31, 2023, ensuring compliance with applicable accounting standards and regulations[96] - The company has established an audit committee to oversee financial reporting and internal controls, in compliance with listing rules[95] - The company has received annual independence confirmation from all independent non-executive directors, affirming their independent status[107] - The board is responsible for maintaining a sound and effective internal control system, while management is tasked with designing and implementing this system[113] Employee and Workplace Practices - The total employee cost, including director remuneration, was approximately $1.3 million for the year ended December 31, 2023, compared to approximately $1.0 million for the year ended December 31, 2022[66] - The company employed 45 employees as of December 31, 2023, an increase of 40.6% from 32 employees in 2022[182] - The company has implemented policies to ensure a safe and healthy work environment, including regular safety checks and fire drills[192] - Employee benefits include comprehensive support for pregnant employees, ensuring their return to original positions post-maternity leave[188] - The company provided 72 hours of training for employees in both 2023 and 2022[194] Financial Liabilities and Management - The company's current liabilities amounted to approximately $225.4 million as of December 31, 2023, with a current ratio of 0.4, down from 0.5 in 2022[44] - The group did not engage in any exploration or development activities during the year ended December 31, 2023, and did not make any significant capital expenditures for upgrading property, plant, and equipment[70] - The company has outstanding debts totaling approximately $181,040,000, which includes amounts payable to the ultimate holding company, banks, and other borrowings[141] - The company is actively negotiating with financial institutions to secure various financing options for operational funding and commitments[142] - The company has taken measures to defer repayment of approximately $60,000,000 due to the ultimate holding company and approximately $18,150,000 in principal and $8,730,000 in interest from independent third-party lenders[138]
恩典生命科技(02112) - 2023 - 中期财报
2023-08-31 12:38
Financial Position - As of June 30, 2023, the group recorded a capital deficit of approximately $91.2 million, compared to $80.3 million as of December 31, 2022[2]. - Current assets amounted to approximately $112.5 million, primarily consisting of trade receivables of $110.5 million, cash and cash equivalents of $0.7 million, and other receivables[2]. - Current liabilities were approximately $218.4 million, including trade payables of $7.8 million and bank borrowings of $54.7 million[2]. - The current ratio as of June 30, 2023, was 0.5, unchanged from December 31, 2022[2]. - As of June 30, 2023, the group recorded negative equity, and the debt-to-equity ratio could not be calculated[3]. - As of June 30, 2023, the total non-current assets amounted to $17,689,000, a decrease from $18,688,000 as of December 31, 2022[26]. - Current assets totaled $112,529,000, down from $114,870,000 in the previous period[26]. - The total current liabilities increased to $218,395,000 from $210,601,000, resulting in a net current liability of $(105,866,000) compared to $(95,731,000) previously[26]. - As of June 30, 2023, total liabilities including amounts due to the ultimate holding company, bank and other borrowings, and bonds amounted to approximately $176,008,000, while cash and cash equivalents were only about $704,000[74]. - The total liabilities increased to $221,439,000 as of June 30, 2023, up from $213,878,000 at the end of December 2022, marking a rise of 3%[129]. Revenue and Loss - The company reported a total comprehensive loss of $(91,221,000) as of June 30, 2023, compared to $(80,320,000) at the end of 2022[26]. - The group reported a net loss of approximately $10,461,000 for the six months ended June 30, 2023[74]. - The company reported a loss before tax of $10,213 thousand for the period, with significant losses in the commercial trading segment amounting to $4,580 thousand[109]. - The company reported a net loss of $13,018,000 for the six months ended June 30, 2023, compared to a loss of $14,488,000 in the same period last year, showing an improvement of 10%[136]. Revenue Breakdown - For the six months ended June 30, 2023, total revenue was $18,433 thousand, with $1,773 thousand from iron ore sales and $16,660 thousand from other products[105]. - The revenue from the iron ore mining and washing business was $4,737 thousand, while the health product business generated $6,682 thousand[109]. - Revenue from iron ore products reached $4,737,000, a significant increase from $1,773,000 in the same period last year, representing a growth of 167%[122]. - Sales of health products amounted to $6,682,000, with no sales recorded in the previous year, indicating the establishment of a new trade line[122]. - Total revenue for the six months ended June 30, 2023, was $15,051,000, compared to $18,433,000 for the same period in 2022, reflecting a decrease of 18%[122]. Cash Flow and Financing - Cash and cash equivalents at the end of the period were $704,000, an increase from $274,000 in the previous year[69]. - The operating cash inflow for the period was $516,000, a turnaround from an outflow of $(857,000) in the same period last year[69]. - The company has a repayment obligation of approximately $21,019,178 (around $2,690,000) related to a statutory demand for debt repayment[182]. - The company has agreed to pay $500,000 monthly to Note 1 holders, with the total amount due on June 30, 2019, equaling all remaining unpaid debts related to Note 1[175]. - The company has not paid any accrued interest on corporate bonds as of June 30, 2023, remaining at zero[184]. Shareholder and Governance - Major shareholders include Yutian holding 50.18% of the shares, and Ample Professional Limited holding 50.13%[18]. - The company has a stock option plan aimed at attracting and retaining top talent, approved on April 12, 2013[21]. - The company has complied with the corporate governance code, except for specific provisions regarding the standards for securities trading by directors[10]. - The group has been continuously reviewing employee compensation packages to ensure competitiveness within the industry[5]. Legal and Compliance Issues - The company has faced legal challenges related to loan defaults, including a lawsuit from OCBC Bank for an outstanding amount of HKD 308,758,494[76]. - The group has implemented restructuring measures due to its inability to meet debt obligations[77]. - The company is seeking legal advice to properly handle a statutory demand for repayment of approximately RMB 250.97 million, which could lead to liquidation proceedings if not addressed[115]. - The group is actively negotiating with all lenders regarding the extension and deferral of defaulted loans, with the board believing that an agreement will be reached in due course[99]. Operational Measures - The group has taken measures to expedite the collection of outstanding trade receivables[80]. - The group is implementing cost control measures, including human resource optimization and management salary adjustments, to manage expenses effectively[118]. - The board has taken measures to alleviate liquidity pressure and improve cash flow, including discussions with various financial institutions for refinancing options[100].
恩典生命科技(02112) - 2022 - 年度财报
2023-03-31 14:19
Financial Performance - The company reported a net loss attributable to owners of approximately $55.74 million for the year ended December 31, 2022[14]. - Revenue for the year 2022 was $32,347,000, representing a 35% increase from $23,978,000 in 2021[24]. - The company reported a loss attributable to owners of $55,740,000, a slight improvement of 2% from a loss of $57,006,000 in the previous year[24]. - Gross profit for the year was $2,500,000, up from $200,000 in 2021, indicating significant growth in profitability[48]. - The total sales revenue for the year ended December 31, 2022, was $32.35 million, an increase of 34.9% compared to $23.98 million in 2021[79]. - Gross profit for the same period was $2.54 million, representing a significant increase of 1,448.2% from $164,000 in 2021[79]. - The gross profit margin improved to 7.85%, up by 7.17 percentage points from 0.68% in the previous year[79]. - The company recorded an annual loss of $5.5 million in 2022, a decrease of about 2% from a loss of $5.7 million in 2021[68]. Financial Position - As of December 31, 2022, the company's current liabilities net amount was approximately $95.73 million, and total liabilities net amount was approximately $80.32 million[14]. - The company has outstanding debts totaling approximately $171.57 million, which includes amounts payable to the ultimate holding company, bank loans, and guaranteed notes[15]. - The total assets decreased by 23% to $133,558,000 from $173,132,000 in 2021[24]. - The current ratio fell to 0.6 from 0.8, indicating a decline in short-term financial health[24]. - The total trade receivables decreased by 23% to $113,854,000 from $148,303,000 in the previous year[24]. - The total liabilities increased, with the debt-to-equity ratio rising to 190% from 120%, reflecting increased financial leverage[24]. - The company's asset-liability ratio as of December 31, 2022, was 187.8%, compared to 116.2% as of December 31, 2021[119]. - The company's current liabilities net increased from approximately $40.5 million as of December 31, 2021, to approximately $95.7 million as of December 31, 2022[114]. Operational Strategies - The company is actively negotiating with existing lenders for the renewal and extension of bank loans and credit financing[12]. - The company is exploring various financing options to secure operational funding and commitments for the foreseeable future[14]. - The company aims to implement measures effectively in 2023 to demonstrate sufficient operational funding for the next twelve months[14]. - The company has outsourced operations at the Ibam mine to local firms due to management and technical personnel being unable to travel to Malaysia[47]. - The company has established a wholly-owned subsidiary in Hong Kong to market plant stem cell products, contributing to diversified revenue streams[44]. - The company plans to diversify its business strategy, focusing on health products as consumer demand shifts from optional to essential[52]. - The company aims to enhance its market presence in the health supplement sector, which is witnessing significant growth in China[52]. Governance and Compliance - The company is committed to maintaining appropriate corporate governance practices to protect shareholder interests and ensure compliance with statutory regulations[155]. - The independent non-executive directors have confirmed their independence according to the listing rules[159]. - The audit committee reviewed the financial reporting procedures and internal controls, ensuring compliance with accounting standards and regulations[168]. - The board has established an audit committee, nomination committee, and remuneration committee to oversee specific matters of the company[191]. - The audit committee reviewed the audited financial statements for the year ended December 31, 2022, confirming compliance with applicable accounting standards and sufficient disclosure[193]. - The remuneration committee is responsible for proposing and approving the remuneration policy for all directors and senior management, ensuring transparency in the process[194]. - The nomination committee evaluates suitable candidates for the board, considering diversity in gender, age, cultural background, and professional experience[197]. Risk Management - The company has established a risk management framework following the COSO model to effectively manage risks[180]. - The company has identified two areas of medium to high risk, including the overall economic downturn in China and strategic risks due to global economic changes[181]. - The company aims to diversify its business and revenue sources in response to economic and political changes[182]. - The company plans to continue engaging external professionals annually to review and enhance its internal control and risk management systems[184].
恩典生命科技(02112) - 2022 - 年度业绩
2023-03-31 14:15
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責, 對其準確性或完整性亦不發表任何聲明,並明確表示概不對因本公告全部或任何 部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 Grace Life-tech Holdings Limited 恩典生命科技控股有限公司 (於開曼群島註冊成立的有限公司) (已委任聯席臨時清盤人) (僅適用於公司重組) (股份代號:02112) 截至二零二二年十二月三十一日止年度的 年度業績公告 恩典生命科技控股有限公司(「本公司」)董事(「董事」)會(「董事會」)欣然宣佈本 公司及其附屬公司截至二零二二年十二月三十一日止年度的經審核綜合財務業績。 本公告載有本公司二零二二年年度報告全文,符合香港聯合交易所證券上市規則 (「上市規則」)中有關年度業績初步公告附載的資料的相關規定。 承董事會命 恩典生命科技控股有限公司 聯席主席 Ng Khing Yeu 香港,二零二三年三月三十一日 於本公告日期,執行董事為李楊先生、Ng Khing Yeu先生、李曉蘭女士及王爾先生; 以及獨立非執行董事為汪靈博士、李忠權博士及梁耀祖先生。 目錄 ...
恩典生命科技(02112) - 2022 - 中期财报
2022-08-31 12:17
Financial Performance - For the six months ended June 30, 2022, the group generated revenue of approximately $18.4 million from the sale of iron ore products and other goods, compared to zero revenue for the same period in 2021[10]. - The group recorded a gross profit of $2.6 million for the six months ended June 30, 2022, while the gross profit for the same period in 2021 was zero[10]. - The group reported a loss of approximately $4.2 million for the six months ended June 30, 2022, an improvement from a loss of approximately $29.6 million for the same period in 2021, primarily due to increased revenue and reduced financing costs[10]. - The company recorded a revenue of approximately $18.4 million for the period, compared to zero in the same period last year[24]. - The sales volume of iron ore products was 14.94 thousand tons, with no sales recorded in the previous year[24]. - The cost of sales for the period was approximately $15.8 million, also compared to zero in the previous year[29]. - The gross profit for the period was approximately $2.6 million, with no gross profit recorded in the same period last year[30]. - The company reported a loss of approximately $4.2 million for the period, a significant decrease from a loss of $29.6 million in the previous year[36]. - Revenue for the six months ended June 30, 2022, was $18.433 million, with a cost of sales of $15.846 million, resulting in a gross profit of $2.587 million[95]. - The company reported a loss before tax of $4.179 million, a substantial improvement from a loss of $29.643 million in the same period last year[95]. - Basic and diluted loss per share for the period was 28 cents, compared to 198 cents in the previous year[95]. - The company reported a net loss of approximately $4,179,000 for the six months ended June 30, 2022, with a net cash outflow from operating activities of about $857,000[109]. - The company’s operating cash flow for the current period was negative, indicating challenges in generating cash from operations[105]. - The company’s total liabilities as of June 30, 2022, were $207.360 million, compared to $193.908 million at the end of the previous year[97]. - The company’s net liabilities increased to $28.271 million from $24.274 million year-on-year[97]. - The company reported total revenue of $18,433,000 for the six months ended June 30, 2022, with $1,773,000 from iron ore sales and $16,660,000 from health and other products[121]. Market and Industry Insights - The iron ore market saw a global shipment total of 750 million tons in the first half of 2022, a year-on-year decrease of 36.67 million tons, representing a decline of 4.7%[18]. - China's iron ore imports decreased significantly, with a total of 563 million tons arriving at ports from January to June 2022, a year-on-year decline of 20.265 million tons[18]. - The production of pig iron in China decreased by approximately 28 million tons, or 6.5%, in the first half of 2022 compared to the same period last year[19]. - The health supplement market in China is projected to reach a market size of 328.3 billion yuan by 2023, indicating a growing demand for health products[22]. Corporate Governance and Compliance - The company is in compliance with the corporate governance code, except for the separation of roles between the chairman and CEO[57]. - The company’s independent non-executive directors are confirmed to be independent as per the requirements of the listing rules[70]. - The company emphasizes a transparent process for determining the remuneration of directors and senior management based on individual and company performance[67]. - The remuneration committee held one meeting during the period to review and discuss the compensation of management and directors[68]. - The nomination committee also conducted one meeting to evaluate the board's structure and recommend suitable candidates[69]. Debt and Financing - As of June 30, 2022, the company's borrowings included approximately $36.5 million from a commercial bank and $52.8 million in notes and bonds[37]. - The company is in default on loans totaling approximately $167,474,000 in principal and $22,001,000 in interest as of June 30, 2022[110]. - The company has been actively negotiating with lenders regarding the extension and deferral of defaulted loans, with management believing that agreements will be reached in due course[113]. - The company has identified various financing options for operational funding and obligations in the foreseeable future[116]. - The company has engaged in discussions with different financial institutions to secure financing options for its operations[116]. - The company’s financial strategy includes managing its debt obligations and ensuring compliance with the terms of its notes to avoid default events[167]. Employee and Operational Insights - The total employee cost for the period, including director remuneration, was approximately $0.4 million, a decrease from $0.5 million in the first half of 2021[46]. - The company employed 32 employees as of June 30, 2022, an increase from 18 employees as of December 31, 2021[46]. - The company has begun to resume mining operations following the lifting of restrictions by the Malaysian government on April 1, 2022[23]. - The company has implemented cost control measures, including optimization of human resources and management salary adjustments[116]. Shareholder Information - As of June 30, 2022, the company’s executive director Li Yang holds 752,750,000 shares, representing 50.18% of the issued share capital[73]. - Ng Khing Yeu, another executive director, holds 112,827,000 shares, accounting for 7.52% of the issued share capital[73]. - Major shareholder Ueda holds 752,750,000 shares, representing approximately 50.18% of the total equity[80]. - The company has disclosed that no other individuals hold more than 5% of the equity as per the Securities and Futures Ordinance[86]. - The company has received notifications regarding the pledging of shares, with Ueda pledging 711,000,000 shares to a third party[83]. Future Plans and Developments - The company is exploring business development opportunities in plant stem cells and has established a wholly-owned subsidiary in Hong Kong to market suitable plant stem cell products[15]. - The company plans to change its name to "Grace Life-tech Holdings Limited," pending shareholder approval[47]. - There were no significant events after the reporting period, aside from the proposed name change[48].
恩典生命科技(02112) - 2021 - 年度财报
2022-05-02 23:13
Financial Performance - Revenue for 2021 was $23.978 million, a decrease of 13.9% from $27.855 million in 2020[5] - The company reported a loss attributable to owners of $57.006 million, an increase of 92.6% compared to a loss of $29.601 million in 2020[5] - Total assets decreased by 26.3% to $173.132 million from $234.988 million in 2020[5] - The gross profit for the year was approximately $0.2 million, a significant improvement from a gross loss of about $0.6 million in 2020, attributed to higher margins from new product lines[32] - The total loss for the year was $57.0 million, an increase of approximately 92.6% from a loss of about $29.6 million in 2020, primarily due to financial asset impairment losses[38] - The company reported a net loss of approximately $57.0 million for the year 2021, an increase of about 92.6% compared to a loss of $29.6 million in 2020[145] Assets and Liabilities - Trade receivables fell by 27.3% to $148.303 million from $204.120 million in 2020[5] - The current ratio decreased to 0.8 from 1.1 in 2020, indicating a decline in liquidity[5] - The debt-to-equity ratio increased to 120.0% from 82.5% in 2020, reflecting higher leverage[5] - As of December 31, 2021, the total capital deficit of the group was approximately $24.3 million, compared to total equity of $34.0 million as of December 31, 2020[39] - The net current asset position decreased from approximately $15.0 million as of December 31, 2020, to a net current liability of approximately $40.5 million as of December 31, 2021[46] - The company's debt-to-equity ratio as of December 31, 2021, was 117.2%, an increase from 82.5% on December 31, 2020[58] Operational Changes - The company entered into a partnership with JD.com, a leading e-commerce platform in China, to expand trade operations[10] - The company established new trade partnerships with leading e-commerce platforms and health product manufacturers to diversify its business strategy[18] - The company focused on commodity trading during the year due to disruptions caused by the COVID-19 pandemic, with no mining or production activities conducted[169] Cost Management - Administrative expenses decreased by approximately 28.6% to about $3.0 million from $4.2 million in 2020, mainly due to reduced legal and professional fees[33] - Financing costs were approximately $12.1 million, down 28.8% from $17.0 million in 2020, due to a revised agreement with independent lenders[34] - The company has been actively negotiating with creditors to avoid immediate loan repayments and has successfully withdrawn a winding-up petition from one creditor[145] Corporate Governance - The board consists of three executive directors and two independent non-executive directors as of December 31, 2021[86] - The company has complied with the corporate governance code except for the role of the chairman and CEO being held by the same person, which deviates from the code[91] - The board is committed to maintaining appropriate corporate governance practices to protect shareholder interests[91] Risk Management - The company identified economic recession and political environment risks as medium to high risks affecting its iron ore mining and sales business[121] - The company has established its enterprise risk management framework in 2016, with the board responsible for maintaining effective internal controls[118] - The audit committee has reviewed internal control assessments and risk evaluations, confirming the effectiveness of the internal control system[126] Sustainability and Environmental Impact - The company is committed to integrating sustainable development concepts into its daily operations and continuously seeks opportunities to improve its performance and corporate strategy[169] - The total greenhouse gas emissions for 2021 were 590.75 kg, a significant decrease of 83% compared to 3,485.96 kg in 2020[189] - The company has not generated any hazardous waste during its daily operations, ensuring compliance with relevant environmental laws[184] Employee Management - The company employed 15 employees as of December 31, 2021, compared to 19 employees in 2020[66] - The employee turnover rate for those aged 31 to 50 years was 87% in 2021, significantly higher than 52% in 2020[200] - The company emphasizes equal opportunities for all employees, with a focus on a friendly and peaceful work environment[196]
恩典生命科技(02112) - 2021 - 中期财报
2021-08-31 14:46
Financial Performance - For the six months ended June 30, 2021, the group reported zero revenue from the sale of crude oil, iron ore products, and other goods, unchanged from the same period in 2020 due to COVID-19 restrictions[8]. - The group recorded a loss of approximately $29.6 million for the six months ended June 30, 2021, compared to a loss of approximately $28.6 million for the same period in 2020, primarily due to the absence of revenue and financial asset impairment losses totaling approximately $17.3 million[8]. - The board did not recommend the payment of an interim dividend for the six months ended June 30, 2021, consistent with the same period in 2020[8]. - The company reported a loss before tax of $29,643 thousand for the six months ended June 30, 2021, compared to a loss of $28,646 thousand in the same period of 2020, indicating a year-over-year increase in losses of approximately 3.5%[89]. - Total comprehensive expenses for the period amounted to $29,261 thousand, up from $29,021 thousand in the previous year, reflecting an increase of about 0.8%[91]. - The company reported a net loss attributable to owners of approximately $29,643,000 for the six months ended June 30, 2021[108]. - The company reported a foreign exchange gain of $382 thousand for the period, compared to a loss of $375 thousand in the previous year, showing a positive turnaround in foreign exchange impact[91]. - The company reported a loss of $29,643,000 for the six months ended June 30, 2021, compared to a loss of $28,646,000 for the same period in 2020[150]. Operational Challenges - The company faced operational suspensions at the Ibam mine due to government-imposed COVID-19 control measures, which have been in effect since March 18, 2020[13]. - The COVID-19 pandemic has significantly impacted the company's cash flow and mineral sales, leading to operational challenges[116]. - The company has implemented timely and proactive measures to ensure the health and safety of all employees during the pandemic[13]. - The company has suspended or reduced production due to government measures since February 2020, affecting its operational capacity[123]. - The company is closely monitoring mining production to avoid any significant unexpected capital cash outflows[127]. Financial Position - As of June 30, 2021, the company's borrowings included approximately $36.5 million from a commercial bank and $48.6 million in notes and bonds[30]. - Total equity as of June 30, 2021, was approximately $4.8 million, down from $34.0 million as of December 31, 2020[34]. - Current assets were approximately $186.1 million, primarily consisting of trade receivables of $177.3 million and cash and cash equivalents of $0.07 million[34]. - Current liabilities totaled approximately $200.0 million, with significant components including bank borrowings of $54.7 million and bonds payable of $48.6 million[34]. - The current ratio as of June 30, 2021, was 0.9, a decrease from 1.1 as of December 31, 2020[34]. - The debt-to-equity ratio increased to 97.2% as of June 30, 2021, compared to 82.5% as of December 31, 2020, due to a decrease in equity[36]. - The company’s total assets less current liabilities stood at $8,207 thousand as of June 30, 2021, a significant decrease from $37,479 thousand at the end of 2020[94]. - The net asset value of the company was reported at $4,752 thousand, down from $34,013 thousand at the end of the previous year, representing a decline of approximately 86%[94]. - The company’s cash and cash equivalents decreased to $68 thousand from $102 thousand year-over-year, indicating a decline of about 33.3%[94]. Shareholder Information - As of June 30, 2021, the executive director Li Yang holds 843,750,000 shares, representing 56.25% of the company's issued share capital[67]. - Major shareholder U-Tian holds 843,750,000 shares, representing 56.25% of the company's equity[74]. - Ample Professional Limited and Hua Rong Hua Qiao Asset Management Co., Ltd. each hold 752,000,000 shares, accounting for 50.13% of the equity[74]. - Haitong International Financial Products (Singapore) Pte. Ltd. has a stake of 172,352,000 shares, which is 11.49% of the equity[74]. Debt and Financing - The company has faced potential liquidation proceedings due to inability to repay debts, with the next hearing scheduled for October 19, 2021[31]. - The company has violated the terms of its overdue borrowings, which could trigger immediate repayment if demanded by lenders[110]. - The company is actively negotiating with lenders regarding the extension and deferral of overdue loans totaling approximately $160,778,000, which includes interest of about $29,145,000[116]. - The company has received an agreement from its ultimate holding company to defer repayment of approximately $60,000,000 until the company is financially capable[118]. - The company has approximately $2,522,000 in cross-default loans due to defaults on certain borrowings[112]. - The company has issued secured notes with a principal amount of approximately $21,270,000, with an annual interest rate of 12%[175]. - The company has renegotiated the terms of certain bank loans, establishing a repayment schedule that includes six installments[167]. Cost Management - Administrative expenses for the period were approximately $2.2 million, a decrease of 4.3% compared to $2.3 million in the first half of 2020[27]. - Employee costs decreased to $489,000 from $661,000 year-on-year, representing a reduction of approximately 26%[148]. - The company is implementing cost control measures to improve cash flow, including monitoring daily operating expenses closely[126]. - The company has taken steps to expedite the collection of overdue trade receivables[118]. Corporate Governance - The Audit Committee is responsible for reviewing the group's financial reporting procedures and internal control systems[59]. - The company has established a Remuneration Committee to review and discuss the remuneration of management and directors to enhance management quality[61]. - The Nomination Committee has been formed to identify and recommend suitable candidates for the board of directors[62]. - The company has confirmed that all independent non-executive directors are independent[63]. - The company has not filled the company secretary position since July 30, 2020, violating Listing Rule 3.28[58].
恩典生命科技(02112) - 2020 - 年度财报
2021-04-30 14:47
CAA RESOURCES CAA Resources Limited 優 庫 資 源 有 限 公 司 * ( 於 開 曼 群 島 註 冊 成 立 的 有 限 公 司 ) 股份代號:02112 * 僅供識別 210 149.16 7% Company OBSERSESSESSED CORPESSBOODSOD 目錄 | --- | --- | |---------------------------|----------------------------------| | | | | 財務及經營概要 主席報告 | 2–3 4–5 | | 管理層討論及分析 | 6–17 | | 企業管治報告 | 18–30 | | 環境、社會及管治報告 | 31–49 | | 董事及高級管理層簡介 | 50–52 | | 董事報告 | 53–64 | | 獨立核數師報告 | 65–69 | | | 70–71 綜合損益及其他全面收益表 | | | 72–73 綜合財務狀況表 | | | 74–75 綜合權益變動表 | | | 76–77 綜合現金流量表 | | | 78–171 綜合財務報表附註 | | | 172–173 ...
恩典生命科技(02112) - 2020 - 中期财报
2020-09-29 08:43
Revenue and Production - For the first half of 2020, the company recorded zero revenue, a decrease of 100% compared to $814.8 million in the same period of 2019[15] - The company's iron ore production and sales volume dropped to zero, down from approximately 1,240 thousand tons in the first half of 2019, representing a 100% decrease[15] - The sales cost for the period was approximately zero, a 100% decrease from about $804.9 million in the first half of 2019, aligning with the revenue drop[19] - The group reported zero revenue from iron ore products and crude oil sales for the six months ended June 30, 2020, compared to $122,372,000 and $492,898,000 for the same period in 2019[118] - The total revenue for the group in the six months ended June 30, 2020, was $0, a significant decrease from $814,757,000 in the same period of 2019[121] Financial Performance - The company recorded a gross loss of approximately $28.6 million for the period, a decrease of 100% compared to a profit of about $2.8 million in the first half of 2019, primarily due to no revenue generated during the period[26] - The company incurred a loss before tax of $28,646 thousand, compared to a profit of $3,454 thousand in the same period of 2019[78] - The total comprehensive loss for the period amounted to $29,021 thousand, compared to a comprehensive income of $1,690 thousand in the previous year[81] - The group incurred a loss of $21,602,000 for the six months ended June 30, 2020, compared to a profit of $5,866,000 in the same period of 2019[126] - The company reported a net loss attributable to shareholders of approximately $28.646 million for the six months ended June 30, 2020[98] Assets and Liabilities - Total equity as of June 30, 2020, was approximately $61.5 million, down from $90.5 million as of December 31, 2019[28] - The company's current ratio as of June 30, 2020, was 1.2, compared to 1.3 as of December 31, 2019, indicating a slight decrease in liquidity[28] - The debt-to-equity ratio increased to 69.4% as of June 30, 2020, from 63.2% as of December 31, 2019, due to a decrease in equity[32] - The company had total borrowings of approximately $54.7 million as of June 30, 2020, consistent with the amount as of December 31, 2019[29] - Total liabilities increased to $183,554 thousand from $182,270 thousand at the end of 2019[83] Operational Challenges - The COVID-19 pandemic led to a complete halt in production activities, with the Ibam mine operations suspended due to government-imposed restrictions[9] - The company is actively negotiating with creditors to extend the repayment period for defaulted borrowings[27] - The company is exploring various financing options with different financial institutions to secure operational funding for the foreseeable future[105] - The COVID-19 pandemic has significantly impacted the company's mineral sales and cash flow, leading to increased uncertainty in operations[111] Employee and Management Information - The company employed 24 staff members as of June 30, 2020, down from 39 as of December 31, 2019, with total employee costs decreasing to approximately $0.6 million from $1.0 million in the same period of 2019[37] - Total compensation for key management personnel for the six months ended June 30, 2020, was USD 317,000, a decrease of 33.4% from USD 476,000 in the same period of 2019[192] - The company’s short-term benefits for management decreased to USD 312,000 from USD 464,000 in the previous year[192] Corporate Governance - The company has complied with the corporate governance code, except for the separation of roles between the Chairman and the CEO, which are held by the same individual[50] - The company has established a remuneration committee to review and discuss the remuneration of management and directors to enhance management quality[54] - The company has established a nomination committee to recommend suitable candidates for the board and assess its structure and composition[55] Shareholder Information - As of June 30, 2020, the CEO holds a beneficial interest in 843,750,000 shares, representing approximately 56.25% of the company's issued share capital[59] - The company reported a significant shareholder structure, with Ueda holding 56.25% of the shares, amounting to 843,750,000 shares[65] - The company has received notifications regarding the pledging of shares, with approximately 50.13% of the issued share capital being pledged[68] Future Plans and Strategies - The company plans to adopt a more cautious operational strategy, focusing on stricter customer credit assessments and risk control measures for receivables[13] - The company is committed to exploring new revenue sources to reverse the current loss situation[13] - The company plans to continue its market expansion and product development strategies in the upcoming periods[92]